Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregnenolone and THC Effects in Healthy Individuals
NCT02811939Phase 1Completed
- Sponsor
- Yale University
- Start
- Apr 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of pregnenolone in psychosis and cognitive impairment, sponsored by Yale University. Started Apr 2016; status: completed.
02
Drugs
pregnenolone
03
Conditions
psychosiscognitive impairment
Beyond the preview
Go deeper on NCT02811939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02811939.